New clinical advances in immunotherapy for the treatment of solid tumours

E-ISSN： 1365-2567|145|2|182-201

ISSN： 0019-2805

Source： IMMUNOLOGY, Vol.145, Iss.2, 2015-06, pp. : 182-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumour Hypoxia: Impact on Biology, Prognosis and Treatment of Solid Malignant Tumours

Oncology Research and Treatment, Vol. 27, Iss. 1, 2004-03 ,pp. : 83-90

Karger

Access to resources Recommend Favorite

Clinical Outcome of Topotecan: New Strategies Play an Important Role in the Treatment of Lung Cancer, Other Solid Tumors, and Hemoblastosis

Oncology Research and Treatment, Vol. 21, Iss. 4, 1999-01 ,pp. : 1-1

Karger

Access to resources Recommend Favorite

Once Daily Sublingual Immunotherapy without Updosing – A New Treatment Schedule

International Archives of Allergy and Immunology, Vol. 140, Iss. 4, 2006-07 ,pp. : 321-326

Karger

Access to resources Recommend Favorite

Advances in the understanding of cancer immunotherapy

BJU INTERNATIONAL, Vol. 116, Iss. 3, 2015-09 ,pp. : 321-329

John Wiley & Sons Inc

Access to resources Recommend Favorite

HX575, Recombinant Human Epoetin Alfa, for the Treatment of Chemotherapy-Associated Symptomatic Anaemia in Patients with Solid Tumours

Oncology Research and Treatment, Vol. 32, Iss. 4, 2009-03 ,pp. : 168-174

Karger

Access to resources Recommend Favorite